10 Surprising Twists in CBD and Cannabis in 2020

10 Surprising Twists in CBD and Cannabis in 2020

10 Surprising Twists in CBD and Cannabis

Cannabidiol (CBD) products came to store shelves last year in a hail of uncertainty.

10 Surprising Twists in CBD and Cannabis in 2020

1. Still No FDA Regulations in Sight

When asked to name the biggest twist of 2020, Lukas didn’t cite COVID-19 or the recession

According to IRI data through June 2020, mainstream retail CBD sales were up 89% year over year

The FDA’s July 9 testing report documented lab testing of CBD products between 2014 and 2020.

When examining the FDA’s testing report, something else stood out to Havens.

Another set of trends emerging from the dispensary channel: infused beverages and smokeable products.

In a channel where consumers spend an average of three to four minutes in the store—and only 21 seconds at checkout, per NACS data—education of a complex new category was always going to be a challenge

Though the mainstream CBD industry is still in its infancy, M&A activity is already picking up.

It wouldn’t be a story about 2020 without mentioning COVID-19

CBD manufacturers are prohibited from making any form of health claims, but that hasn’t stopped consumers from educating themselves on the positive effects

  • Page 1